(Q34719806)

4 August 2017

1 reference

title

Quinolones in the treatment of lower respiratory tract infections caused by intracellular pathogens (English)

1 reference

4 August 2017

0 references

C. Chidiac

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1804785

29 November 2022

Y. Mouton

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1804785

29 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1804785

29 November 2022

publication date

1 January 1991

1 reference

full work available at URL

4 August 2017

http://link.springer.com/content/pdf/10.1007/BF01715829.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/BF01715829

http://link.springer.com/article/10.1007/BF01715829/fulltext.html

29 November 2022

1 reference

https://api.crossref.org/works/10.1007/BF01715829

http://link.springer.com/content/pdf/10.1007/BF01715829

29 November 2022

1 reference

https://api.crossref.org/works/10.1007/BF01715829

29 November 2022

1 reference

4 August 2017

volume

19 Suppl 7

1 reference

4 August 2017

page(s)

S365-71

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01715829

4 August 2017

exact match

0 references

cites work

Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones

1 reference

https://api.crossref.org/works/10.1007%2FBF01715829

In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01715829

Antimycoplasmal activity of ofloxacin (DL-8280).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01715829

In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01715829

In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01715829

Penetration of ofloxacin into human lung tissue following a single oral dose of 200 milligrams

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01715829

Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01715829

Comparative postantibacterial activities of pefloxacin, ciprofloxacin, and ofloxacin against intracellular multiplication of Legionella pneumophila serogroup 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01715829

Antibiotic susceptibilities of two Coxiella burnetii isolates implicated in distinct clinical syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01715829

In vitro susceptibilities of Coxiella burnetii, Rickettsia rickettsii, and Rickettsia conorii to the fluoroquinolone sparfloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01715829

In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01715829

Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01715829

Efficacy of pefloxacin in comparison with erythromycin in the treatment of experimental guinea pig legionellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01715829

In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01715829

Comparison of the activity of three antibiotic regimens in severe Legionnaires' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01715829

Comparative susceptibility of Mycoplasma pneumoniae to erythromycin, ciprofloxacin, and lomefloxacin.

21 January 2018

1 reference

12 December 2020

Treatment of legionellosis with ofloxacin in kidney transplanted patients. Lack of interaction with cyclosporin A

1 reference

12 December 2020

The effect of ofloxacin on the intracellular growth of Legionella pneumophila in guinea pig alveolar phagocytes

1 reference

12 December 2020

Diffusion of ofloxacin into human lung tissue

1 reference

12 December 2020

The penetration of ofloxacin into lung tissue

1 reference

12 December 2020

Ciprofloxacin in the treatment of legionellosis in critically ill patients including those cases unresponsive to erythromycin

1 reference

12 December 2020

[Evaluation of ciprofloxacin versus amoxicillin + clavulanic acid or erythromycin for the empiric treatment of community-acquired pneumonia]

1 reference

12 December 2020

The penetration of ofloxacin into bronchial secretions

1 reference

12 December 2020

Use of fluoroquinolones for intracellular pathogens

1 reference

12 December 2020

Treatment of pneumonia caused by Legionella, Mycoplasma, Chlamydiae and Rickettsia using ofloxacin

1 reference

12 December 2020

A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections

1 reference

12 December 2020

Bronchial penetration of ofloxacin after single and multiple oral dosage

1 reference

12 December 2020

Inhibition of Legionella pneumophila in guinea pig peritoneal macrophages by new quinolone, macrolide and other antimicrobial agents.

1 reference

12 December 2020

[In vitro activity of new quinolones against Mycoplasma pathogenic to humans].

1 reference

12 December 2020

The comparative in-vitro activity of ofloxacin

1 reference

12 December 2020

Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections

1 reference

12 December 2020

New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01715829

1 reference

Dimensions Publication ID

4 August 2017

1010444699

0 references

1 reference